ALTAVANT SCIENCES HOLDINGS LIMITED
Company number 11007316
- Company Overview for ALTAVANT SCIENCES HOLDINGS LIMITED (11007316)
- Filing history for ALTAVANT SCIENCES HOLDINGS LIMITED (11007316)
- People for ALTAVANT SCIENCES HOLDINGS LIMITED (11007316)
- More for ALTAVANT SCIENCES HOLDINGS LIMITED (11007316)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
19 Nov 2024 | GAZ1(A) | First Gazette notice for voluntary strike-off | |
07 Nov 2024 | DS01 | Application to strike the company off the register | |
15 Oct 2024 | CS01 | Confirmation statement made on 10 October 2024 with no updates | |
30 Dec 2023 | AA | Full accounts made up to 31 March 2023 | |
18 Oct 2023 | CS01 | Confirmation statement made on 10 October 2023 with updates | |
06 Oct 2023 | TM01 | Termination of appointment of Mark Craig as a director on 6 October 2023 | |
06 Oct 2023 | AP01 | Appointment of Ms Emma Carys Price as a director on 6 October 2023 | |
21 Apr 2023 | RP04CS01 | Second filing of Confirmation Statement dated 10 October 2022 | |
31 Oct 2022 | CS01 |
Confirmation statement made on 10 October 2022 with updates
|
|
12 Oct 2022 | AD01 | Registered office address changed from Suite 1, 3rd Floor 11 - 12 st. James's Square London SW1Y 4LB United Kingdom to 7th Floor 50 Broadway London SW1H 0DB on 12 October 2022 | |
12 Oct 2022 | AA | Full accounts made up to 31 March 2022 | |
03 Oct 2022 | SH20 | Statement by Directors | |
03 Oct 2022 | SH19 |
Statement of capital on 3 October 2022
|
|
03 Oct 2022 | CAP-SS | Solvency Statement dated 21/09/22 | |
03 Oct 2022 | RESOLUTIONS |
Resolutions
|
|
12 Aug 2022 | AP01 | Appointment of Mr Mark Craig as a director on 5 August 2022 | |
12 Aug 2022 | TM01 | Termination of appointment of Sunil Masson as a director on 5 August 2022 | |
22 Apr 2022 | PSC09 | Withdrawal of a person with significant control statement on 22 April 2022 | |
22 Apr 2022 | PSC02 | Notification of Sumitomo Pharma Co., Ltd. as a person with significant control on 27 December 2019 | |
08 Apr 2022 | SH01 |
Statement of capital following an allotment of shares on 30 March 2022
|
|
22 Dec 2021 | AA | Full accounts made up to 31 March 2021 | |
19 Oct 2021 | CS01 | Confirmation statement made on 10 October 2021 with updates | |
29 Mar 2021 | SH01 |
Statement of capital following an allotment of shares on 29 March 2021
|
|
27 Oct 2020 | AA | Full accounts made up to 31 March 2020 | |
12 Oct 2020 | CS01 | Confirmation statement made on 10 October 2020 with updates |